ProCE Banner Activity

Interdisciplinary Hemophilia A Education: Conversation Between Hematologists on the Evolution of Long-term Patient Care

Slideset Download
Download this slideset from an interactive presentation on the evolution of long-term care for patients with hemophilia A and how to address barriers to adherence.

Released: April 07, 2022

Expiration: April 06, 2023

No longer available for credit.
Begin Activity

Share

Faculty

Glaivy Batsuli

Glaivy Batsuli, MD

Assistant Professor of Pediatrics
Pediatric Hematologist
Division of Pediatric Hematology and Oncology
Department of Pediatrics
Emory University
Pediatric Hematologist
Pediatric Hematology and Oncology
Aflac Cancer and Blood Disorders Center of Childrens Healthcare of Atlanta
Atlanta, Georgia

Guy A. Young

Guy A. Young, MD

Professor of Pediatrics
University of Southern California
Keck School of Medicine
Director
Hemostasis and Thrombosis Center
Childrens Hospital Los Angeles
Los Angeles, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Genentech, a member of the Roche Group

Partners

NHF

ProCE Banner

Faculty Disclosure

Primary Author

Glaivy Batsuli, MD

Assistant Professor of Pediatrics
Pediatric Hematologist
Division of Pediatric Hematology and Oncology
Department of Pediatrics
Emory University
Pediatric Hematologist
Pediatric Hematology and Oncology
Aflac Cancer and Blood Disorders Center of Childrens Healthcare of Atlanta
Atlanta, Georgia

Glaivy Batsuli, MD, has disclosed that she has received consultant/advisor/speaker fees from Bio Products Laboratories and Kedrion.

Guy A. Young, MD

Professor of Pediatrics
University of Southern California
Keck School of Medicine
Director
Hemostasis and Thrombosis Center
Childrens Hospital Los Angeles
Los Angeles, California

Guy Young, MD, has disclosed that he has received consulting fees from Apcintex, BioMarin, Genentech/Roche, Grifols, Novo Nordisk, Pfizer, Rani, Sanofi Genzyme, Spark, Takeda, and UniQure and funds for research support from Genentech/Roche, Grifols, and Takeda.